BridgeMD
New treatment option for Anastomotic Leak
Official title PARLAR-02 Trial：Modified Transanal Drainage Tube Use for Preventing Anastomotic Leakage
ClinicalTrials.gov ID: NCT07036588
What this study is testing
- What it's testing
- Surgical resection remains the primary treatment for rectal cancer, but the postoperative incidence of anastomotic leakage (AL) is relatively high. AL not only increases the medical burden on patients, prolongs hospital stays, raises the need for secondary surgery, and elevates perioperative mortality, but also increases the long-term risk of local recurrence and reduces survival rates.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Rectal adenocarcinoma (confirmed by pathology);
- Tumor location: The lower edge is ≤10 cm from the anal verge;
- Age: ≥18 and ≤80 years old;
- ASA ≤3 ;
- After assessment, laparoscopic/robotic sphincter - preserving surgery for rectal cancer is feasible;
You likely can't join if
- Emergency surgery;
- Presence of multiple primary colorectal cancers;
- History of long - term use of immunosuppressants or corticosteroids;
- Patients with severe mental illness or uncontrolled infection before surgery;
- Pregnant or breastfeeding women;
- Bowel obstruction before surgery.
See the full eligibility criteria
- Rectal adenocarcinoma (confirmed by pathology);
- Tumor location: The lower edge is ≤10 cm from the anal verge;
- Age: ≥18 and ≤80 years old;
- ASA ≤3 ;
- After assessment, laparoscopic/robotic sphincter - preserving surgery for rectal cancer is feasible;
- T2 - 4N0 - 3M0\~T0 - 1N1 - 3M0 \& non- local recurrence;
- Signed informed consent form;
- Able to understand the risks of participating in the trial.
- Emergency surgery;
- Presence of multiple primary colorectal cancers;
- History of long - term use of immunosuppressants or corticosteroids;
- Patients with severe mental illness or uncontrolled infection before surgery;
- Pregnant or breastfeeding women;
- Bowel obstruction before surgery.
The study team makes the final eligibility decision.
Where it's taking place
- Yuzhong, Chongqing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Yuzhong, Chongqing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.